Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.23
Delayed Data
As of Apr 24
 +0.01 / +0.45%
Today’s Change
1.53
Today|||52-Week Range
4.20
+21.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsShort Term Investment Cash-8.9M25.0M34.4M-31.6M
 
 
 
 
 
Cash & Short Term Investments27.2M52.0M86.4M55.2M
 
 
 
 
 
 
ReceivablesReceivables4.8M1.4M2.1M1.9M
 
 
 
 
 
 
InventoriesInventories279.0K4.0M8.0M6.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses235.0K251.0K286.0K369.0K
 
 
 
 
 
Other Current Assets0.003.3M1.2M1.4M
 
 
 
 
Current Assets32.5M61.1M97.9M65.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross29.4M31.1M32.0M32.7M
 
 
 
 
 
Depreciation-11.1M-14.8M-18.3M-21.5M
 
 
 
 
 
Other Assets1.0M1.3M1.7M1.7M
 
 
 
 
 
Total Assets51.8M78.7M113.3M78.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.0M5.3M5.3M4.0M
 
 
 
 
 
Accrued Expenses3.9M6.2M4.9M12.8M
 
 
 
 
 
Other Current Liabilities11.3M18.7M19.9M21.0M
 
 
 
 
 
Other Liabilities18.7M25.8M26.7M26.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0067.0M67.5M
 
 
 
Other Liabilities6.6M5.4M2.4M912.0K
 
 
 
 
 
Total Liabilities77.9M82.1M140.3M134.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-26.1M-3.4M-26.9M-55.6M
 
 
 
 
 
Total Shareholder Equity-26.1M-3.4M-26.9M-55.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding85.6M93.5M93.6M93.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account